All articles by Prameela vegi
Trial separation: Brexit effect on pharma
In 2019, the UK will end its membership of the EU, and with it a series of mechanisms that bind it to a continent-wide set of regulations for clinical trials. Emma Cave, a professor of healthcare law at Durham University, tells Greg Noone about the uncertainty felt among pharmaceutical companies regarding the future of the sector post-Brexit.